Answers are grounded in this paper and cite their sources.
Recently published data indicate that morbidity after ESWL of large (>2 cm) renal calculi can be significantly diminished by inserting a ureteral double-J stent prior to treatment. A prospective randomized study was designed to clarify if ESWL plus ureteral stenting is preferable to the combination of percutaneous nephrolithotomy and ESWL for the treatment of large renal calculi (>2.5 cm) and staghorn stones. To date, 74 patients have entered the study, and ≥3-month follow-up data are available on 54. Complications (bleeding, septicemia, deterioration of renal function) were significantly more frequent in the entire series following percutaneous manipulation and ESWL (24% versus 3%), whereas the need for auxiliary measures (mainly percutaneous nephrostomies) was greater following stent insertion plus ESWL (25% versus 16%). After an average follow-up of 3 months, only 15% of the patients treated with ESWL and ureteral stenting were free of stones and none was stone free at hospital discharge, whereas the stone-free rates at discharge and 3 months in the group undergoing percutaneous manipulation plus ESWL were 41% and 66%, respectively. These data suggest that longer follow-up is necessary for the assessment of the definitive value of ESWL plus stenting in the treatment of large renal calculi. With the availability of anesthesia-free ESWL in the Dornier HM3, this topic is currently of particular interest.
No takes yet. Share an insight, caveat, or question.
Miller et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: